Genpact Ltd
NYSE:G
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
30.56
46.82
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
G Price Targets Summary
Genpact Ltd
According to Wall Street analysts, the average 1-year price target for G is 48.13 USD with a low forecast of 35.35 USD and a high forecast of 57.75 USD.
G Last Price Targets
Genpact Ltd
The latest public price target was made on Nov 12, 2024 by Dan Dolev from Mizuho Securities , who expects G stock to rise by 7% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Analyst | Price Target | Date | Article |
---|---|---|---|
Dan Dolev
Mizuho Securities
|
45
USD
Upside 7% |
1 month ago
Nov 12, 2024
|
Genpact Ltd. (G) PT Raised to $45 at Mizuho
StreetInsider
|
David Koning
Robert W. Baird
|
44
USD
Upside 4% |
2 months ago
Oct 9, 2024
|
Genpact price target raised to $44 from $38 at Baird
TheFly
|
Keith Bachman
BMO Capital
|
42
USD
Downside 0% |
4 months ago
Aug 12, 2024
|
Genpact price target raised to $42 from $38 at BMO Capital
TheFly
|
Bryan Keane
Deutsche Bank
|
37
USD
Downside 12% |
6 months ago
Jun 12, 2024
|
Deutsche Bank Reiterates Hold Rating on Genpact Ltd. (G)
StreetInsider
|
Keith Bachman
BMO Capital
|
38
USD
Downside 10% |
7 months ago
May 10, 2024
|
Genpact Ltd. (G) PT Lowered to $38 at BMO Capital
StreetInsider
|
Keith Bachman
Loop Capital Markets
|
46
USD
Upside 9% |
1 year ago
May 11, 2023
|
Incrementally Harder Path Ahead Of Genpact, This Analyst Does Not Envision An Upside
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is G's stock price target?
Price Target
48.13
USD
According to Wall Street analysts, the average 1-year price target for G is 48.13 USD with a low forecast of 35.35 USD and a high forecast of 57.75 USD.
What is Genpact Ltd's Revenue forecast?
Projected CAGR
8%
For the last 8 years the compound annual growth rate for Genpact Ltd's revenue is 8%. The projected CAGR for the next 4 years is 8%.
What is Genpact Ltd's Operating Income forecast?
Projected CAGR
15%
For the last 8 years the compound annual growth rate for Genpact Ltd's operating income is 8%. The projected CAGR for the next 4 years is 15%.
What is Genpact Ltd's Net Income forecast?
Projected CAGR
4%
For the last 8 years the compound annual growth rate for Genpact Ltd's net income is 13%. The projected CAGR for the next 4 years is 4%.